As the biopharmaceutical industry continues to evolve, so do the tools and strategies used to drive commercial success. One such tool that has gained significant traction in recent years is digital content. According to the Veeva Pulse Field Trends Report, sharing digital content during meetings with healthcare professionals (HCPs) can have a measurable promotional impact, driving 2.5x new patient starts over calls that don’t share content (Veeva Pulse Field Trends Report, p.1).
So, what makes digital content so powerful in biopharmaceutical sales? For one, it allows sales reps to provide HCPs with educational materials on scientific evidence supporting a given treatment and answering common questions (Veeva Pulse Field Trends Report, p.2). This not only helps HCPs make informed decisions about treatment options but also positions the sales rep as a trusted source of information.
Another advantage of digital content is its versatility. Whether it’s shared during an in-person meeting or via video channels, digital content has been shown to have a consistent promotional impact across both channels (Veeva Pulse Field Trends Report, p.2). This means that sales reps can use digital content to engage HCPs regardless of their location or preferred method of communication.
Of course, simply sharing digital content during HCP meetings is not enough to drive commercial success. Sales reps need to know how to use it effectively. This is where training comes in. According to the Veeva Pulse Field Trends Report, companies should invest in training their field team on how to use digital content to engage HCPs and drive new patient starts (Veeva Pulse Field Trends Report, p.2). Finally, measuring the impact of shared digital content is crucial for refining strategy and identifying which types of content are most effective. Companies should measure the impact of shared digital content on new patient starts and other key performance indicators (KPIs) to determine its effectiveness (Veeva Pulse Field Trends Report, p.2).
In conclusion, the Veeva Pulse Field Trends Report highlights the power of digital content in biopharmaceutical sales. By providing HCPs with educational materials, being versatile across channels, investing in training, and measuring impact, companies can leverage digital content to drive commercial success.
On this link, you can watch the full video: https://www.veeva.com/resources/veeva-pulse-field-trends-insights-to-inform-hcp-engagement/